These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1381941

  • 1. Treatment of chemotherapy-induced neutropenia in children with subcutaneously administered recombinant human granulocyte colony-stimulating factor.
    Okamura J, Yokoyama M, Tsukimoto I, Komiyama A, Sakurai M, Imashuku S, Miyazaki S, Ueda K, Hanawa Y, Takaku F.
    Pediatr Hematol Oncol; 1992; 9(3):199-207. PubMed ID: 1381941
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK, He XH, Yang S, Wang HQ, Jiang ZF, Zhu YZ, Ke XY, Zhang Y, Liu YP, Zhang WJ, Wang Z, Shi QZ, Xie XD, Zhang HL, Wang JJ, Luo DY, Zheng QS, Sun RY.
    Zhonghua Yi Xue Za Zhi; 2006 Dec 26; 86(48):3414-9. PubMed ID: 17313855
    [Abstract] [Full Text] [Related]

  • 3. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
    Shi YK, Liu P, Yang S, Han XH, He XH, Ai B, Qin Y, Li B, Huang DZ, Zhang CG, Sun Y.
    Ai Zheng; 2006 Apr 26; 25(4):495-500. PubMed ID: 16613688
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
    Huang W, Liu J, Zeng Y, Wu F, Li N, Chen K, Hong Y, Wang L, Zhen H, Lin L.
    Cancer Chemother Pharmacol; 2018 Oct 26; 82(4):607-613. PubMed ID: 30043207
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies.
    Lydaki E, Bolonaki E, Stiakaki E, Dimitriou H, Kalmantis T, Kalmanti M.
    Pediatr Hematol Oncol; 1995 Oct 26; 12(6):551-8. PubMed ID: 8589000
    [Abstract] [Full Text] [Related]

  • 6. Clinical trial of recombinant granulocyte colony-stimulating factor for chemotherapy-induced neutropenia patients with oral cancer.
    Iwase M, Yoshiya M, Kakuta S, Nagumo M.
    J Oral Maxillofac Surg; 1997 Aug 26; 55(8):836-40; discussion 841. PubMed ID: 9251612
    [Abstract] [Full Text] [Related]

  • 7. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
    Misaki M, Ueyama Y, Tsukamoto G, Matsumura T.
    Br J Cancer; 1998 Mar 26; 77(6):884-9. PubMed ID: 9528829
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of intravenous recombinant human granulocyte colony-stimulating factor (rhG-CSF) in children receiving myelosuppressive cancer chemotherapy: clearance increases in relation to absolute neutrophil count with repeated dosing.
    Sturgill MG, Huhn RD, Drachtman RA, Ettinger AG, Ettinger LJ.
    Am J Hematol; 1997 Feb 26; 54(2):124-30. PubMed ID: 9034286
    [Abstract] [Full Text] [Related]

  • 9. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia.
    Bernini JC, Wooley R, Buchanan GR.
    J Pediatr; 1996 Oct 26; 129(4):551-8. PubMed ID: 8859262
    [Abstract] [Full Text] [Related]

  • 10. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
    Ema H, Suda T, Sakamoto S, Tomonaga T, Tsunoda J, Muroi K, Komatsu N, Miwa A, Ohsaka A, Yoshida M.
    Jpn J Cancer Res; 1989 Jun 26; 80(6):577-82. PubMed ID: 2474526
    [Abstract] [Full Text] [Related]

  • 11. Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma.
    Yoshida T, Nakamura S, Ohtake S, Okafuji K, Kobayashi K, Kondo K, Kanno M, Matano S, Matsuda T, Kanai M.
    Cancer; 1990 Nov 01; 66(9):1904-9. PubMed ID: 1699654
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S, Shi YK, Liu P, Han XH, He XH, Cai YM, Chen ZM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 01; 28(3):339-44. PubMed ID: 16900629
    [Abstract] [Full Text] [Related]

  • 13. Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients.
    Terashi K, Oka M, Ohdo S, Furukubo T, Ikeda C, Fukuda M, Soda H, Higuchi S, Kohno S.
    Antimicrob Agents Chemother; 1999 Jan 01; 43(1):21-4. PubMed ID: 9869559
    [Abstract] [Full Text] [Related]

  • 14. Treatment of idiopathic neutropenia in the elderly with recombinant human granulocyte colony-stimulating factor.
    Sonoda Y, Yashige H, Fujii H, Maekawa T, Abe T.
    Acta Haematol; 1991 Jan 01; 85(3):146-52. PubMed ID: 1710409
    [Abstract] [Full Text] [Related]

  • 15. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
    Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS.
    Blood; 1994 Sep 01; 84(5):1427-33. PubMed ID: 7520770
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
    Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, Kurtzberg J.
    Blood; 2001 Jan 15; 97(2):376-82. PubMed ID: 11154211
    [Abstract] [Full Text] [Related]

  • 17. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K, Obuchi M, Watanabe M, Kusaka M, Seki M.
    Oncol Res; 1995 Jan 15; 7(3-4):165-71. PubMed ID: 8555650
    [Abstract] [Full Text] [Related]

  • 18. Comparative effect of 100 versus 250 micrograms/m2/day of G-CSF in pediatric patients with neutropenia induced by chemotherapy.
    Kubota M, Akiyama Y, Mikawa H, Tsutsui T.
    Pediatr Hematol Oncol; 1995 Jan 15; 12(4):393-7. PubMed ID: 7577392
    [Abstract] [Full Text] [Related]

  • 19. Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis.
    Zuppa AA, Girlando P, Florio MG, Cota F, Romagnoli C, Tortorolo G.
    Eur J Obstet Gynecol Reprod Biol; 2002 May 10; 102(2):131-6. PubMed ID: 11950479
    [Abstract] [Full Text] [Related]

  • 20. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
    Eguchi K, Etou H, Miyachi S, Morinari H, Nakada K, Noda K, Ohkuni Y, Watanabe K, Yamada Y, Ohe Y.
    Eur J Cancer; 1994 May 10; 30A(2):188-94. PubMed ID: 7512356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.